Abstract
By computer search, we identified one potential NF-κB binding site in the HPV16 long control region (LCR) at position 7554–7563 having two mismatches in comparison to the consensus NF-κB binding site of the Igκ L promoter. Bandshift experiments with nuclear extracts from HeLa cells or purified glutathione S-transferase–p65 fusion protein clearly demonstrated that NF-κB is able to bind to this region of the LCR. However, in comparison to NF-κB binding on a consensus probe, the affinity of NF-κB for this site is about 250-fold reduced. When mutations were introduced into this NF-κB binding site, the activity of the LCR was increased, strongly suggesting that NF-κB was acting as a transcriptional repressor in the context of the HPV16 LCR. In addition, overexpression of NF-κB p65 repressed the activity of the HPV16 LCR, strengthening this conclusion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
